![Neil McCullough](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil McCullough bekleidet die Position des Executive Vice President-Quality & Compliance bei ICON plc. In der Vergangenheit hatte Dr. McCullough die Position des Senior Director-Global Research & Development bei Pfizer Inc. und des Vice President-Global Quality & Compliance bei Pharmaceutical Product Development LLC inne. Er erhielt einen Doktortitel von der University of Kent und einen Abschluss vom Hibernia College.
| Unternehmen | Position | Ende |
|---|---|---|
| ICON PUBLIC LIMITED COMPANY | Compliance Officer | 01.10.2020 |
| PFIZER INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Compliance Officer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Commercial Services |
ICON plc
 ICON plc Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
University of Kent
 University of Kent Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hibernia College
 Hibernia College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
